Navigation Links
Telik Announces Fourth Quarter and 2011 Year End Financial Results and 2012 Financial Guidance
Date:2/23/2012

rials, (2) seeking corporate partnerships and funding for development and commercialization of its drug product candidates and (3) advancing its leading preclinical oncology drug candidate.

Financial Outlook

For the full year 2012, Telik anticipates total operating costs and expenses to be in the range of $12.0 million to $13.0 million, which includes stock-based compensation expense of approximately $0.8 million. The company's cash utilization for the full year 2012 is expected to be in the range of $13.0 million to $14.0 million and will have to raise additional funds through equity or debt financings in order to meet its 2012 cash requirements.  There is no assurance Telik will be successful in obtaining additional funding.

About TelikTelik, Inc. of Palo Alto, CA, is a clinical stage drug development company focused on discovering and developing small molecule drugs to treat cancer.  The company's most advanced drug candidate is Telintra®, a modified glutathione analog intended for the treatment of hematologic malignancies including myelodysplastic syndrome; followed by Telcyta®, a cancer activated prodrug for the treatment of a variety of cancers. Telik's product candidates were discovered using its proprietary drug discovery technology, TRAP®, which enables the rapid and efficient discovery of small molecule drug candidates.

Forward Looking StatementsThis press release contains "forward looking" statements, including statements regarding Telik's financial outlook and expected cash utilization for 2012 and the future development of TELINTRA, TELCYTA, preclinical drug candidates and potential corporate partnerships. These forward looking statements are based upon Telik's current expectations. There are important factors that could cause Telik's results to differ materially from those indicated by these forward-looking statements, including, among others, that Telik would be unable to continue to fund its
'/>"/>

SOURCE Telik, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Telik Announces Presentation and Webcast at 14th Annual BIO CEO & Investor Conference
2. Telik Announces Telintra Clinical Presentations at the Annual Meeting of the American Society of Hematology
3. Telik Announces Third Quarter 2011 Financial Results
4. Telik Announces Publication of a Report of Complete Response of G-CSF Resistent Severe Idiopathic Chronic Neutropenia Following Treatment with Telintra®
5. Telik Announces Ezatiostat (Telintra®) Preclinical Presentation at the 2011 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
6. Telik Announces Initiation of a Phase 2b Clinical Trial of Telintra® (Ezatiostat HCL) in Patients With Low to Intermediate-1 Risk Non-Deletion (5q) Myelodysplastic Syndrome
7. Telik Announces Publication in the Journal Cancer of a Phase 2 Randomized Multicenter Study of Two Extended Dosing Schedules of Oral Ezatiostat in Low to Intermediate-1 Risk Myelodysplastic Syndrome
8. Telik Announces First Quarter 2011 Financial Results
9. Telik Announces Presentation of New Data on the Characterization of Novel Ezatiostat (TELINTRA®, TLK199) Analogs at American Association for Cancer Research Annual Meeting
10. Telik Announces Presentation and Webcast at 10th Annual Needham Healthcare Conference
11. Telik Announces Fourth Quarter and 2010 Year End Financial Results and 2011 Financial Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... , May 26, 2015  OrthoAccel ® Technologies, ... its own growth accelerating in response to continued demand ... treatment. Now available in 2,500 practice locations in the ... daily, OrthoAccel,s AcceleDent ® is the only FDA-cleared ... speed up orthodontic treatment by as much as 50 ...
(Date:5/26/2015)... Cellular testing for pharmaceuticals - how ... future of technologies for screening cells? Now discover ... ahead there for data, benefiting your influence. For ... opportunities and revenue forecasts. That new ... possible for cell-based assays and related ...
(Date:5/26/2015)...  BioSpecifics Technologies Corp. (NASDAQ: BSTC ), a ... as XIAFLEX ® in the U.S. and XIAPEX ... President, Tom Wegman , will present a corporate ... The presentation will take place on Monday, ... New York, NY . A live webcast ...
Breaking Medicine Technology:OrthoAccel Technologies Continues Trajectory of Accelerated Growth with Over 2,500 Practice Locations 2OrthoAccel Technologies Continues Trajectory of Accelerated Growth with Over 2,500 Practice Locations 3Cell-Based Assays: World Industry and Market Prospects 2015-2025 2Cell-Based Assays: World Industry and Market Prospects 2015-2025 3Cell-Based Assays: World Industry and Market Prospects 2015-2025 4Cell-Based Assays: World Industry and Market Prospects 2015-2025 5Cell-Based Assays: World Industry and Market Prospects 2015-2025 6Cell-Based Assays: World Industry and Market Prospects 2015-2025 7BioSpecifics Technologies Corp. to Present at the Jefferies 2015 Healthcare Conference 2
(Date:5/27/2015)... 27, 2015 The Advanced Fertility Center of ... open for business to better serve the needs of couples ... Park neighborhood on the Northwest side of the city at ... be arranged by calling the Chicago office at (773) 794–1818. ... Fertility Center of Chicago. The other 2 offices are ...
(Date:5/26/2015)... 27, 2015 Carey Danis & ... testosterone gel lawsuit . The suit pertains to AndroGel, ... was filed in late April 2015, and a court ... Illinois federal court in mid-May.¹ , Testosterone gel lawsuits ... the Northern District of Illinois. The multidistrict litigation (MDL) ...
(Date:5/26/2015)... May 27, 2015 Securityhunter ... (MATOC) by the United States Department of Health and ... The MATOC was awarded through the General ... (FSS) for the PSC, which is a fee-for-service agency. ... one year options, and is an enterprise–wide physical security ...
(Date:5/26/2015)... 2015 Forex Income Boss is a ... their results trading in the foreign exchange market. The ... utilizes 10 customer indicators to help traders locate perfect ... usual, Russ Horn's latest trading system is the talk ... reports Tiffany Hendricks, senior product reviewer at HonestyFirstReview.com. "While ...
(Date:5/26/2015)... Beloved local Arizona company, Parker and Sons, outdoes itself ... guarantee or else its free. , Parker and Sons ... here . What’s more, Parker and Sons offers a customer ... company’s rich legacy, and immense success. , The sixty ... imaginable. Whether it be low water flow or complete clogging, ...
Breaking Medicine News(10 mins):Health News:The Advanced Fertility Center of Chicago Opens a New Fertility Office Location in Chicago 2Health News:Carey Danis & Lowe Comments on Recently Filed Testosterone Gel Lawsuit 2Health News:Securityhunter Has Been Awarded a Multiple Award Task Order Contract (MATOC) by the Department of Health and Human Services 2Health News:Forex Income Boss - Review Of Russ Horn's New FX Trading System Released 2Health News:Parker and Sons Offers Special, Sixty Minute Drain Clean Guarantee or Else It’s on Them 2
... September 3 , - Despite ... Year , Nucletron, a global leader ... half year of 2009. Despite challenging,global economic conditions, Nucletron surpassed ... Net sales amounted to EUR 51.2 million, a 3% growth ...
... , , PHOENIX, Sept. 2 ... southwestern United States, has formed a strategic alliance with American National ... getting claims compensated in a timely manner with a proprietary process ... , , "Over the last 10 years ...
... 2 MedQuist Inc. (Nasdaq: MEDQ ) today ... credit facility. The credit facility provides committed revolving funding ... may increase its maximum credit up to $40 million, based ... a working capital facility that may be used for general ...
... , , ... Liberty Screening Services Ltd.,s new Southeastern U.S. account executive. ... and oversee uniform background-screening strategies for clients throughout the ... Services offers background-screening services for Fortune 500 clients and ...
... BETHESDA, Md., Sept. 2 /PRNewswire-Asia/ -- Chindex ... provider of Western,healthcare products and services in the People,s Republic of ... -- Morgan Stanley Healthcare Corporate Day, to be held ... MA. Management will meet with institutional investors, ...
... , ATLANTA, Sept. 2 /PRNewswire-FirstCall/ ... a leading provider of comprehensive home health services, announced today that ... Magna Home Health), a part of the Rush Health System, located ... from Gentiva,s existing cash reserves. , , "We ...
Cached Medicine News:Health News:Nucletron Increases Full Year Outlook After Strong First Half 2009 2Health News:MedQuist Announces Establishment of Revolving Credit Facility and Payment of Special Cash Dividend 2Health News:Chindex International Announces September Investor Conferences Participation 2Health News:Gentiva(R) Health Services Completes Acquisition of Home Health Agency 2Health News:Gentiva(R) Health Services Completes Acquisition of Home Health Agency 3
A compact mobile System Cart gives mobility within your department. The cart accomodates the Uromac Median data processor, desktop computer, printer and provides stowage space. Patient related transd...
... is ideal for any clinical setting, ... performing a UDS procedure. Customize Delphis™ ... options of a Pocket PC, a ... with Bluetooth™ wireless technology allows you ...
... Designed and manufactured by Laborie, ... equipment. Solenette™ provides credible tracings. ... measurements of true parameters. Designed ... or Medical Professional to be ...
... with ease of use make the OM-5 ... Ideal for office or hospital-based urodynamics, the ... cystometry, leak point pressure, or urethral pressure ... make the OM-5 flexible enough to meet ...
Medicine Products: